Search for: "Bayer and Bayer" Results 141 - 160 of 3,409
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Apr 2022, 10:40 am by Dennis Crouch
” In re Bayer Aktiengesellschaft, 488 F.3d 960, 963 (Fed. [read post]
31 Mar 2022, 6:05 am by Searcy Law
These lawsuits have been filed against Johnson & Johnson, Janssen Pharmaceuticals, Bayer and Merck & Co., which are the companies that manufacture Avelox, Cipro and Levaquin. [read post]
31 Mar 2022, 6:05 am by Searcy Law
These lawsuits have been filed against Johnson & Johnson, Janssen Pharmaceuticals, Bayer and Merck & Co., which are the companies that manufacture Avelox, Cipro and Levaquin. [read post]
31 Mar 2022, 6:05 am by Searcy Law
These lawsuits have been filed against Johnson & Johnson, Janssen Pharmaceuticals, Bayer and Merck & Co., which are the companies that manufacture Avelox, Cipro and Levaquin. [read post]
In two separate judgments, the Full Court has provided much needed clarity on how to identify the pharmaceutical products that can support a valid patent term extension in Australia, as Natalie Shoolman, Kent Teague and Rose Jenkins explain in this article. [read post]
29 Mar 2022, 9:03 pm by Dan Flynn
Bayer filed a petition with the Supreme Court to reverse a lower court decision that upheld $25 million in damages awarded to California resident Edwin Hardeman. [read post]
26 Mar 2022, 3:49 pm
 Jane LambertPatents Court (Mr Justice Mellor) Teva Pharmaceutical Industries Ltd and another Bayer Healthcare LLC [2021] EWHC 2690 (Pat) (8 Oct 2021)This was an action for the revocation of EP (UK) 2,305,255 under s.72 (1) (a) of the Patents Act 1977:"Subject to the following provisions of this Act, the court or the comptroller may by order revoke a patent for an invention on the application of [read post]
14 Mar 2022, 2:47 am by admin
The Los Angeles City Attorney’s Office proclaimed last Monday that it is suing Bayer […] [read post]
2 Mar 2022, 2:29 pm by Flaxman Law Group
The Mirena IUD sparked lawsuits after thousands of women experienced damage to their uteruses when using the device and Bayer reached settlements in more than 19000 cases linked to its Yaz birth control pills, which some women claimed caused blood clots, strokes, and heart attacks. [read post]
2 Mar 2022, 2:44 am by Frantzeska Papadopoulou
Furthermore, Hanna has in-house experience of the life sciences industry, having worked at the global life sciences company Bayer with responsibility for legal affairs, corporate compliance and data protection primarily in Sweden but also in relation to global issues, including working out of the pharma HQ in Berlin. [read post]
24 Jan 2022, 1:19 am by Rose Hughes
The Board of Appeal did not agree, and found that there was no reason in the prior art for the skilled person to have rejected the use of an anti-Blys antibody as one of a number of the obvious alternatives (compare the recent UK High Court decision in Bayer v Teva on whether the selection of a formulation salt was obvious to try, IPKat). [read post]
17 Jan 2022, 1:08 am by Rose Hughes
Whilst the fact of the cases differ, the PTAB and CAFC reasoning in Teva vs Corcept is markedly different, for example, to the reasoning of the UK High Court in Bayer v Teva [2021] EWHC 2690 (Pat) (IPKat) and Actavis v ICOS (IPKat), in which inventions arising from multi-step drug development programs were found obvious-to-try in view of a known treatment effect for a particular drug, regardless of whether there was an unpredictable technical effect. [read post]
12 Jan 2022, 8:38 am by Kluwer Patent blogger
“In 2012, India’s first ever compulsory license was granted by the Indian Patent Office to Natco Pharma for generic production of Bayer Corp’s Nexaver® (Sorafenib Tosylate), a life-saving medicine used for treating liver and kidney cancer. [read post]
11 Jan 2022, 9:05 pm by Dan Flynn
After that loss, Bayer agreed to fund a $30 billion settlement with thousands of other lawsuits filed in state and local courts. [read post]
6 Jan 2022, 1:22 pm by Kevin LaCroix
  The answer to this question, at least with respect to the Bayer lawsuit, is “No. [read post]
3 Jan 2022, 12:39 pm by Kevin LaCroix
The directors’ and officers’ liability environment is always changing, but 2021 was a particularly eventful year, with important consequences for the D&O insurance marketplace. [read post]